Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (stock code: 01349) announced that, as of January 31, 2026, its total registered share capital remained RMB 103,657,210. The company reported 326,000,000 H shares and 710,572,100 A shares, each with a par value of RMB 0.1, with no changes from the previous month.

The announcement confirmed that the public float requirement for its H shares was met in accordance with the minimum threshold of 25%. There were no share repurchases, treasury shares, or other movements in issued shares during the reporting period.